ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility
29 mai 2017 16h37 HE
|
ABcann Medicinals; Cannabis Wheaton Income Corp.
VANCOUVER, British Columbia, May 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX.V:ABCN) (formerly Panda Capital Inc.) (“ABcann”) and Cannabis Wheaton Income Corp. (TSX.V:CBW) ("Cannabis...
ABcann Extends Agreement With Medical Cannabis Pioneer
09 mai 2017 07h30 HE
|
ABcann Medicinals
OTTAWA, May 09, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that Raphael Mechoulam has agreed to extend his role as an advisor to the...
ABcann Global Announces Appointment of W. Brett Wilson to Advisory Board
04 mai 2017 08h30 HE
|
ABcann Medicinals
NAPANEE, Ontario, May 04, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the...
ABcann Global Announces Closing of Qualifying Transaction and Concurrent Financings
03 mai 2017 11h06 HE
|
ABcann Medicinals
NAPANEE, Ontario, May 03, 2017 (GLOBE NEWSWIRE) -- ABCANN GLOBAL CORPORATION (TSX-V:ABCN) (formerly Panda Capital Inc.) (“ABcann” or the “Company”) is pleased to announce that it has completed its...
Panda and ABcann Medicinals Announce Multi-Stage Product Testing Methodology
24 avr. 2017 09h00 HE
|
ABcann Medicinals
OTTAWA, April 24, 2017 (GLOBE NEWSWIRE) -- Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce details of the multi-stage product testing methodology at ABcann Medicinals Inc....
Panda And ABcann Medicinals Announce Increase In Concurrent Subscription Receipt Financing And Also Announce Results of Annual General Meeting
12 avr. 2017 14h46 HE
|
ABcann Medicinals
OTTAWA, April 12, 2017 (GLOBE NEWSWIRE) -- Panda Capital Inc. (NEX:PDA.H) (the “Company”) today announces an increase in the size of its concurrent subscription receipt financing (the “Financing”),...
Panda and ABcann Medicinals Announce Conditional Approval of Qualifying Transaction
30 mars 2017 14h02 HE
|
ABcann Medicinals; Panda Capital Inc.
OTTAWA, Ontario, March 30, 2017 (GLOBE NEWSWIRE) -- Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the...